Story perspectives

MIT Develops mRNA Treatment to Enhance Aging Immune Response

1/16/2026

44 5

Summary

Story summary

Massachusetts Institute of Technology researchers developed a liver-targeted mRNA treatment to boost immune responses in aging mice.
The approach compensates for thymic involution, which reduces T-cell production with age.
Lipid nanoparticles deliver mRNA to liver cells, prompting production of proteins that help T cells respond to vaccines and cancer therapies.
Further testing is needed to confirm safety and effectiveness in humans, but the approach could support vaccines during flu season.

1 of 1

Story summary

Massachusetts Institute of Technology researchers developed a liver-targeted mRNA treatment to boost immune responses in aging mice.
The approach compensates for thymic involution, which reduces T-cell production with age.
Lipid nanoparticles deliver mRNA to liver cells, prompting production of proteins that help T cells respond to vaccines and cancer therapies.
Further testing is needed to confirm safety and effectiveness in humans, but the approach could support vaccines during flu season.